Cargando…
Interferon-gamma release assays for diagnosis of latent TB infection in chronic kidney diseases and dialysis patients
INTRODUCTION: Patients with chronic kidney disease (CKD), especially end-stage kidney disease (ESKD), are at risk of developing tuberculosis (TB). The prevalence and predictors of LTBI assessed by a high-sensitivity, high-specificity test such as an interferon-gamma release assay (IGRA) has not been...
Autores principales: | Hayuk, Pattorn, Boongird, Sarinya, Pornsuriyasak, Prapaporn, Bruminhent, Jackrapong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701719/ https://www.ncbi.nlm.nih.gov/pubmed/36452296 http://dx.doi.org/10.3389/fcimb.2022.1046373 |
Ejemplares similares
-
Epidemiology and Outcomes of Early-Onset and Late-Onset Adenovirus Infections in Kidney Transplant Recipients
por: Bruminhent, Jackrapong, et al.
Publicado: (2019) -
Diagnostic Accuracy of Interferon-Gamma Release Assays for Tuberculous Meningitis: A Systematic Review and Meta-Analysis
por: Wen, An, et al.
Publicado: (2022) -
Comparison of interferon gamma release assay and CXCL9 gene expression assay for the detection of Mycobacterium bovis infection in African lions (Panthera leo)
por: Gumbo, Rachiel, et al.
Publicado: (2022) -
Performance of Interferon-Gamma Release Assays in the Diagnosis of Nontuberculous Mycobacterial Diseases—A Retrospective Survey From 2011 to 2019
por: Yang, Chi, et al.
Publicado: (2021) -
Combination of Blood Routine Examination and T-SPOT.TB Assay for Distinguishing Between Active Tuberculosis and Latent Tuberculosis Infection
por: Luo, Ying, et al.
Publicado: (2021)